General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amarin(SIGNIFICANT), Sanofi(MODEST), Esperion(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Amarin(SIGNIFICANT), Novartis Corporation(SIGNIFICANT)

View Full Disclosure